Lupin Gets FDA Final Nod to Market Generic Seasonale Tablets

Lupin Pharmaceuticals received final approval for its levonorgestrel and ethinyl estradiol tablets, USP 0.15 mg/0.03 mg, from the FDA to market a generic version of Teva Pharmaceuticals’ Seasonale tablets.
RTTNews